Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
about
Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsAdaptation of the central retina for high acuity vision: cones, the fovea and the avascular zoneAge-related changes in brain support cells: Implications for stroke severityBlood-CNS Barrier Impairment in ALS patients versus an animal modelTNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier propertiesThe link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeEarly gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model.Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune SystemAlpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factorsHypoxia induces angiogenic factors in brain microvascular endothelial cells.Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viabilityDysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz.Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect.Polymorphisms in genes involved in oxidative stress response in patients with sudden sensorineural hearing loss and Ménière's disease in a Japanese population.Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE.Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.Unique biology of gliomas: challenges and opportunities.Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitariusImmunologic privilege in the central nervous system and the blood-brain barrier.Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variationsHuman and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survivalMonocyte/macrophages and their role in HIV neuropathogenesis.HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson's disease.Susceptibility to focal and global brain ischemia of Alzheimer mice displaying aβ deposits: effect of immunoglobulinNovel models for assessing blood-brain barrier drug permeation.The immunological challenges of cell transplantation for the treatment of Parkinson's disease.Brain rust: recent discoveries on the role of oxidative stress in neurodegenerative diseases.Regulation of claudins in blood-tissue barriers under physiological and pathological statesEndothelial dysfunction: the link between homocysteine and hydrogen sulfide.Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.In vitro micro-physiological models for translational immunology.Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
P2860
Q26770462-0E8AD00D-CB43-4C81-AE94-D938AC1D5980Q26851676-0728D9E2-B04C-4650-AD0F-F2D746EEAEA0Q26860372-4F3237E0-1E41-4345-A10F-AD2C6631D62EQ26860478-6DFAA966-34CD-49A2-B6A4-3418629A926AQ27026792-D970667B-5147-483B-AA1C-9938C096352EQ28484667-65F30184-D264-45A6-9D06-18157607F1CBQ30830414-21F2558E-6FCD-4B10-8110-E3D75FA5B3ACQ34432509-40A320FB-1FDB-493A-B8E7-AC0FFCF2C4E4Q34587752-778E5BCE-C14A-42ED-88F4-BADBD67FA504Q34603199-8FB4241B-C836-40A5-AAC3-438DE1EC8904Q35058419-5311618F-A3B6-46BD-AE55-B1CDC7066335Q35330589-1B71A048-1D28-410F-9A76-6FE91367B899Q35664117-EA5A74A3-6745-474C-8B4E-703F411C5E7EQ35749135-70729125-5E42-403A-B8F4-7C16D922107EQ35754099-DD0D515D-175A-498C-A850-333E61FE509BQ35878024-23CAE10C-9D83-470C-ACE1-D4BC8AD8D648Q35897840-10339E4D-C981-40EB-AE94-77F00CE4461DQ36076183-6D9CFE83-C287-413F-A3F9-A7272D3787D3Q36280856-46B79737-EC8F-4638-A2C8-6E15B39AD878Q36410269-9BA2EA21-7BD1-4525-BE2C-12377D1520F8Q36476035-1A5EA9B1-CF46-4A25-91B3-D6268279D5DDQ36604934-D6576068-DDFA-4C89-92A9-FEA92394DB66Q36626214-AE2038F1-DD33-434B-877E-13806B4F83DEQ36635045-370AF6C8-0CE6-451C-B57E-D644B1680E85Q36684162-9CC9F1A5-D0C6-44A7-A84B-CE59930A7AEAQ36795245-2A09A95C-1224-434B-B4A3-A75F970B6025Q36880688-5082CC7E-93E2-4DB4-BD6B-227B4310AAA5Q36991666-94BFBC2C-D18E-45D7-B88B-55515DFCFFA9Q37199557-77A792BA-F7B2-4590-B5CE-1CEF60E4F553Q37267022-84569EC7-9DEE-4470-837D-9B7628EA7254Q37665371-38C83C63-956A-4CA7-9C51-59F108BEDC19Q37999058-CE4DBA87-200D-474C-AE31-320448F1D631Q38004257-8AC4EA8E-5FE1-4264-A3CE-6A01C506624CQ38009974-20179DDC-D1A9-407F-81B3-AD1AB8DFD26DQ38199105-36789FA0-57B8-481B-A94D-F3E87418029EQ38227415-2131B765-6803-45E3-8382-597AB6AA2934Q38241183-113E6C3B-F24D-4D88-A6E8-0E13FDAF9C94Q38260925-E5058062-A3E3-46F9-8498-FB23F1A87E47Q38287065-DF17E3BA-ADC1-40FF-9FCA-502A0A99918FQ38365567-642457AD-FA6A-41AD-9791-4082FCF96ACB
P2860
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@en
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@nl
type
label
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@en
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@nl
prefLabel
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@en
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@nl
P2093
P2860
P921
P1476
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
@en
P2093
Bradley Miller
Joseph Martinez
Paula Grammas
P2860
P356
10.1017/S1462399411001918
P577
2011-06-10T00:00:00Z